US Drug Recall Register
Class III · Low risk Terminated Initiated Aug 5, 2015 (11 years ago)

Topicort

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification results for impurities testing was obtained at the 6 and 9 month time points.

What was recalled

Topicort (desoximetasone) Topical Spray, 0.25%, 100 mL Bottles, Rx Only. Mfd by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada, L6T 1C1, Dist by: TaroPharma, Hawthorne, NY 10532. NDC: 51672-5281-7.

Recalling firm
Taro Pharmaceuticals, Inc.
Origin
N/A, Canada
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1370-2015

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Desoximetasone recalls

See all
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-030-99 D-0678-2022
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 52565-045-99 D-0677-2022
Class II · Moderate risk Terminated

Desoximetasone Ointment USP

Reason cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Teligent Pharma, Inc. NDC 70512-037-10 D-0676-2022
Class II · Moderate risk Terminated

Desoximetasone Topical Spray

Reason Failed Impurities/Degradation Specification; high out of specification results observed

Lupin Pharmaceuticals Inc. D-0866-2020
Class II · Moderate risk Terminated

Desoximetasone USP

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8634-2 D-0483-2018